Cited by 414Parkinson's Disease Mechanisms and TreatmentsCellular transport and secretionAlzheimer's disease research and treatments

Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes

Open access
Abounit, Saïda, Bousset, Luc, Loria, Frida, Zhu, Seng, de Chaumont, Fabrice, Pieri, Laura, Olivo‐Marin, Jean‐Christophe, Melki, Ronald +1 more·2016·The EMBO Journal

Abstract

Synucleinopathies such as Parkinson's disease are characterized by the pathological deposition of misfolded α-synuclein aggregates into inclusions throughout the central and peripheral nervous system. Mounting evidence suggests that intercellular propagation of α-synuclein aggregates may contribute to the neuropathology; however, the mechanism by which spread occurs is not fully understood. By using quantitative fluorescence microscopy with co-cultured neurons, here we show that α-synuclein fibrils efficiently transfer from donor to acceptor cells through tunneling nanotubes (TNTs) inside lysosomal vesicles. Following transfer through TNTs, α-synuclein fibrils are able to seed soluble α-synuclein aggregation in the cytosol of acceptor cells. We propose that donor cells overloaded with α-synuclein aggregates in lysosomes dispose of this material by hijacking TNT-mediated intercellular trafficking. Our findings thus reveal a possible novel role of TNTs and lysosomes in the progression of synucleinopathies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201593411

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • α-synuclein fibrils damage lysosomes and propagate between neurons via lysosome-associated cargo transported through tunneling nanotubes.

    “Concurrently, α-syn fibrils damage lysosomes and propagate between neurons via lysosome-associated cargo transported through TNTs, providing a TNT-dependent route for pathology spread [151,152].”

    From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [151]

    The Abstract reports that α-synuclein fibrils move between co-cultured neurons through TNTs inside lysosomal vesicles. The Discussion reports enlarged lysosomes but presents fibril-induced lysosomal impairment as a hypothesis, not a demonstrated finding. Page numbers were not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • αSyn has the ability to spread via direct neuron-to-neuron transfer.

    “iii) αSyn has the ability to spread to adjacent cells via secretion in exosomes [209], uptake via endocytosis [210] and cell-surface receptors like HSPGs, or even direct neuron-to-neuron [211, 212] or astrocyte-to-neuron [213] transfer via tunneling nanotubes (Fig. 2).”

    From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [211]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C.
Affiliations
  • Institut Pasteur (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Zurzolo, Chiara
Venue
The EMBO Journal
Published
2016-08-22
Volume
35
Issue
19
Pages
2120-2138
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2512060277
Cited by
414
References
72
Citations by year
2026: 28 · 2025: 28 · 2024: 54 · 2023: 34 · 2022: 44 · 2021: 44 · 2020: 55 · 2019: 40 · 2018: 45 · 2017: 32 · 2016: 9
FWCI
31.55
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Ministère de l'Education Nationale
  • Fondation Bettencourt‐Schueller
  • Fondation pour la Recherche Médicale (FDT20140931208, DEQ20140329557)
  • Marie Skłodowska‐Curie Fellowship
  • China Scholarship Council
  • MI CARNOT ICSA/PMI
  • Agence Nationale de la Recherche (ANR‐14‐JPCD‐0002‐01)
  • Fondation de France (2015‐00060936)
  • Centre National de la Recherche Scientifique
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
tunneling nanotubes, alpha-synuclein, lysosomes, intercellular trafficking, synucleinopathies, Parkinson's disease, lysosomal escape, neurons
MeSH terms
Amyloid, Animals, Cell Communication, Cells, Cultured, Lysosomes, Microscopy, Fluorescence, Neurons, Coculture Techniques, Nanotubes, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review